Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kari Lancaster

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Global Public Health|November 15, 2021
New directions for participatory modelling in health: Redistributing expertise in relation to localised matters of concernSophie Adams, Tim Rhodes, Kari Lancaster
Drug and Alcohol Review|August 18, 2012
Public opinion and drug policy in Australia: engaging the 'affected community'Kari Lancaster, Alison Ritter, Jennifer Stafford
Addiction (Abingdon, England)|October 10, 2020
Recovery from alcohol problems in the absence of treatment: a qualitative narrative analysisRichard Mellor, Kari Lancaster, Alison Ritter
The International Journal on Drug Policy|May 13, 2015
Producing the 'problem of drugs': A cross national-comparison of 'recovery' discourse in two Australian and British reportsKari Lancaster, Karen Duke, Alison Ritter
The International Journal on Drug Policy|July 25, 2016
The stigmatisation of 'ice' and under-reporting of meth/amphetamine use in general population surveys: A case study from AustraliaJenny Chalmers, Kari Lancaster, Caitlin Hughes
The International Journal on Drug Policy|June 30, 2015
Laws prohibiting peer distribution of injecting equipment in Australia: A critical analysis of their effectsKari Lancaster, Kate Seear, Carla Treloar
BMJ Open|September 28, 2022
How do care environments shape healthcare? A synthesis of qualitative studies among healthcare workers during the COVID-19 pandemicMia Harrison, Tim Rhodes, Kari Lancaster
Health (London, England : 1997)|January 28, 2021
Pharmaceutical citizenship in an era of universal access to hepatitis C treatment: Situated potentials and limitsJake Rance, Tim Rhodes, Kari Lancaster
BMJ Global Health|February 27, 2024
In search of a 'good number': knowledge controversy and population estimates in the endgame of hepatitis C eliminationTim Rhodes, Kari Lancaster, Sophie Adams
The International Journal on Drug Policy|April 13, 2019
"Towards eliminating viral hepatitis": Examining the productive capacity and constitutive effects of global policy on hepatitis C eliminationKari Lancaster, Tim Rhodes, Jake Rance
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Global Public Health|November 15, 2021
New directions for participatory modelling in health: Redistributing expertise in relation to localised matters of concernSophie Adams, Tim Rhodes, Kari Lancaster
Drug and Alcohol Review|August 18, 2012
Public opinion and drug policy in Australia: engaging the 'affected community'Kari Lancaster, Alison Ritter, Jennifer Stafford
Addiction (Abingdon, England)|October 10, 2020
Recovery from alcohol problems in the absence of treatment: a qualitative narrative analysisRichard Mellor, Kari Lancaster, Alison Ritter
The International Journal on Drug Policy|May 13, 2015
Producing the 'problem of drugs': A cross national-comparison of 'recovery' discourse in two Australian and British reportsKari Lancaster, Karen Duke, Alison Ritter
The International Journal on Drug Policy|July 25, 2016
The stigmatisation of 'ice' and under-reporting of meth/amphetamine use in general population surveys: A case study from AustraliaJenny Chalmers, Kari Lancaster, Caitlin Hughes
The International Journal on Drug Policy|June 30, 2015
Laws prohibiting peer distribution of injecting equipment in Australia: A critical analysis of their effectsKari Lancaster, Kate Seear, Carla Treloar
BMJ Open|September 28, 2022
How do care environments shape healthcare? A synthesis of qualitative studies among healthcare workers during the COVID-19 pandemicMia Harrison, Tim Rhodes, Kari Lancaster
Health (London, England : 1997)|January 28, 2021
Pharmaceutical citizenship in an era of universal access to hepatitis C treatment: Situated potentials and limitsJake Rance, Tim Rhodes, Kari Lancaster
BMJ Global Health|February 27, 2024
In search of a 'good number': knowledge controversy and population estimates in the endgame of hepatitis C eliminationTim Rhodes, Kari Lancaster, Sophie Adams
The International Journal on Drug Policy|April 13, 2019
"Towards eliminating viral hepatitis": Examining the productive capacity and constitutive effects of global policy on hepatitis C eliminationKari Lancaster, Tim Rhodes, Jake Rance
Pageof 8